Aimebenomon Idahosa

Family Medicine physician in San Francisco, California — also lists obesity medicine in the CMS registry.

Practice Details

Address
2443 Fillmore St # 38015799
San Francisco, CA 94115
Geocoded location: 37.7920, -122.4345
Taxonomy
Family Medicine
Credential
MD
NPPES Enumeration
Listed with NPPES since 2019
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
NPPES Record Updated
October 2025

Specialty taxonomies on file (2)

  • Obesity Medicine
    Preventive Medicine, Obesity Medicine
  • Family Medicine
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Aimebenomon Idahosa is a Family Medicine physician in San Francisco whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 613 Family Medicine practices in San Francisco carrying this exact taxonomy in our directory.

What to expect at a Family Medicine visit

Family-medicine practices manage routine and preventive care for all ages. A weight- or GLP-1-related visit often involves:

  • A general health and medication review in the context of your overall care.
  • Screening labs where indicated (A1c, metabolic panel) before starting therapy.
  • A conversation about whether GLP-1 therapy or a referral to a specialist is the better fit.
  • Coordination with your insurance on coverage and prior authorization.

This is general guidance for family medicine practices, not a description of Aimebenomon Idahosa's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 165-086-5517.

GLP-1 access in San Francisco, California

Adult obesity rate
28.1%
#44 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$219/mo
Typical California telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
California Medicaid, obesity indication

About 28.1% of California adults have obesity (BMI 30+), ranking the state #44 of 50 (CDC BRFSS). Our directory currently lists 144 GLP-1-relevant clinics in San Francisco. If a cash-pay route makes more sense, compounded semaglutide through California telehealth averages about $219/mo — well below brand-name Wegovy or Zepbound.

Explore more California options on the best California GLP-1 providers page, browse every San Francisco listing in the San Francisco clinic directory.

Related Practices in San Francisco

Other San Francisco listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to California addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured California telehealth partners:

Featured Partners · San Francisco

Featured GLP-1 providers serving San Francisco

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  2. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  3. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  4. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
  5. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  6. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →

See more San Francisco options on the San Francisco clinic directory, our San Francisco GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by San Francisco obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Aimebenomon Idahosa's specialty taxonomy but not the specific medications it prescribes or its current service menu. Aimebenomon Idahosa is listed under Family Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 165-086-5517 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Aimebenomon Idahosa's primary specialty on file is Family Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Aimebenomon Idahosa is located at 2443 Fillmore St # 38015799, San Francisco, CA 94115. The phone number listed in the registry is 165-086-5517. Its full record is public in the CMS National Provider registry under NPI 1821651910.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Aimebenomon Idahosa is currently accepting new patients. Call the practice at 165-086-5517 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.